🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Parthasarathy Chandrakesan

University of Oklahoma Health Sciences Center

ORCID: 0000-0002-7587-9553

Also affiliated with Core Laboratories (United States)

MedicineImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Discovery and Development of a Novel mPGES-1/5-LOX Dual Inhibitor LFA-9 for Prevention and Treatment of Chronic Inflammatory Diseases”.

Discovery and Development of a Novel mPGES-1/5-LOX Dual Inhibitor LFA-9 for Prevention and Treatment of Chronic Inflammatory Diseases

Journal of Inflammation Research(2020)10.2147/jir.s286110
N/A
0DataRank · unranked
14 citations

Gopal Pathuri, Hariprasad Gali, S. Terzyan, Janani Panneerselvam, Parthasarathy Chandrakesan +5 more

Tuft and Cancer Stem Cell Marker DCLK1: A New Target to Enhance Anti-Tumor Immunity in the Tumor Microenvironment

Cancers(2020)10.3390/cancers12123801
N/A
0DataRank · unranked
43 citations

Nathaniel Weygant, Parthasarathy Chandrakesan, Courtney W. Houchen, Jun Peng, Dongfeng Qu +1 more

DCLK1-Isoform2 Alternative Splice Variant Promotes Pancreatic Tumor Immunosuppressive M2-Macrophage Polarization

Molecular Cancer Therapeutics(2020)10.1158/1535-7163.mct-19-0776
N/A
0DataRank · unranked
35 citations

Janani Panneerselvam, Randal May, Nathaniel Weygant, Dongfeng Qu, William L. Berry +6 more